Elizabeth Holmes, founder and CEO of Theranos, speaks at the Fortune Global Forum in San Francisco, Monday, Nov. 2, 2015. Her fear of needles led her to drop out of Stanford at 19 to commercialize a blood test that relied on a finger prick instead of drawing blood from a vein. She became the youngest person ever to be given the Horatio Alger Award and was appointed to the board of fellows of Harvard Medical School. Time magazine named her to its list of the world’s 100 most-influential people. Her closely held company was recently valued at $9 billion, making her a multibillionaire.
Elizabeth Holmes, founder and CEO of Theranos, speaks at the Fortune Global Forum in San Francisco, Monday, Nov. 2, 2015. Her fear of needles led her to drop out of Stanford at 19 to commercialize a blood test that relied on a finger prick instead of drawing blood from a vein. She became the youngest person ever to be given the Horatio Alger Award and was appointed to the board of fellows of Harvard Medical School. Time magazine named her to its list of the world’s 100 most-influential people. Her closely held company was recently valued at $9 billion, making her a multibillionaire. Jeff Chiu Associated Press file
Elizabeth Holmes, founder and CEO of Theranos, speaks at the Fortune Global Forum in San Francisco, Monday, Nov. 2, 2015. Her fear of needles led her to drop out of Stanford at 19 to commercialize a blood test that relied on a finger prick instead of drawing blood from a vein. She became the youngest person ever to be given the Horatio Alger Award and was appointed to the board of fellows of Harvard Medical School. Time magazine named her to its list of the world’s 100 most-influential people. Her closely held company was recently valued at $9 billion, making her a multibillionaire. Jeff Chiu Associated Press file

Barry Ritholtz: How words betrayed two medical giants

November 07, 2015 6:16 AM